Both in Biotechnology
enGene Therapeutics vs Caribou Biosciences
Over the past year ENGN returned −69.8% and CRBU returned −46.1%; their daily moves had a correlation of 0.16.
ENGN −69.8% CRBU −46.1%Growth of $1, one year, split-adjusted
| Metric | ENGN | CRBU |
|---|---|---|
| Price | $1.95 | $1.24 |
| Market cap | $130.7M | $132.9M |
| Today | −1.02% | +0.81% |
| 1 month | +6.8% | −23.5% |
| 6 months | −68.4% | −27.9% |
| Year to date | −78.4% | −22.0% |
| 1 year | −70.0% | −41.8% |
| Revenue growth (YoY) | — | −43.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −1619.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 13.2× |
| Net cash | $241.0M | $112.3M |
| Dividend yield | — | — |
| Volatility (60d) | 45.3% | 50.6% |
| Short % of float | 2.7% | 15.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).